FRAZER, Pa., Jan. 4 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) announced today that Frank Baldino, Jr., Ph.D., Chairman and CEO will
present at the JP Morgan Healthcare Conference being held at the Westin St.
Francis Hotel in San Francisco, CA. Dr. Baldino will deliver a one hour
presentation on Tuesday, January 8, 2008 beginning at 2:00 p.m. Pacific
Time (11 a.m. Eastern Time).
Live Web Cast and Archived Replay
Members of the financial and investment community, the media and other
interested parties can access a live web cast of the presentation through
the investor relations section of the company's website http://www.cephalon.com.
Following the live presentation, a replay of the presentation will be
available for two weeks on the company's website.
About Cephalon, Inc.
Cephalon, Inc. is an international biopharmaceutical company dedicated
to the discovery, development and commercialization of innovative products
in four core therapeutic areas: central nervous system, pain, oncology and
addiction. A member of the Fortune 1000, Cephalon currently employs
approximately 3,000 people in the United States and Europe. U.S. sites
include the company's headquarters in Frazer, Pennsylvania, and offices,
laboratories or manufacturing facilities in West Chester, Pennsylvania,
Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's
European headquarters are located in Maisons-Alfort, France.
The company's proprietary products in the United States include:
PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet)
[C-II], TRISENOX, AMRIX(R) (cyclobenzaprine hydrochloride extended-release
capsules), VIVITROL(R) (naltrexone for extended-release injectable
suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM)
(armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl
citrate) [C-II]. The company also markets numerous products
internationally. Full prescribing information on its U.S. products is
available at http://www.cephalon.com or by calling 1-800-896-5855.
SOURCE Cephalon, Inc.
 back to top
Related links:
http://www.cephalon.com
http://www.prnewswire.com/comp/134563.html /
CONTACT:
Media, Sheryl Williams, +1-610-738-6493,
swilliam@cephalon.com, or Investors, Robert (Chip) Merritt,
+1-610-738-6376, cmerritt@cephalon.com, both of Cephalon, Inc.
|
